Adding transcriptomics to the bead-enabled accelerated monophasic multi-omics method is a step toward universal sample preparation


In modern biology, scientists are using powerful tools to study the complex molecules that make up living organisms. These molecules—proteins, lipids, metabolites, and RNA—are like pieces of a puzzle that fit together to form the bigger picture of how biological systems function. To get a complete understanding of this puzzle, researchers need to study all these molecules together, not just one at a time. This is where multi-omics comes in.
What is Multi-Omics?
Multi-omics is a research approach that combines several different types of biological data (known as “omics”) to give a more comprehensive view of how life works at the molecular level. For example, proteomics studies proteins, lipidomics focuses on lipids (fats), metabolomics looks at small molecules produced in the body, and transcriptomics examines RNA. Each of these “omics” tells us something different about what’s happening in cells and tissues.
When you combine data from all of these fields, you can get a deeper and more complete understanding of biological systems. This is crucial for studying diseases, developing treatments, and even personalizing medicine. However, preparing samples for multi-omics analysis has been challenging because it requires extracting all these different molecules from the same sample, and the tools to analyze the data are not always available for all “omics” fields.
The mBAMM Method: A Breakthrough
A new technique called mBAMM (modified bead-enabled accelerated monophasic multi-omics) has been developed at the Los Alamos National Laboratory. This method allows scientists to extract RNA for transcriptomics (studying gene activity) alongside proteins, lipids, and metabolites from the same sample. Previous methods could isolate proteins, lipids, and metabolites, but adding RNA into the mix was difficult.
mBAMM makes it possible to perform RNA sequencing (RNA-seq) without losing any of the other molecules in the process. This is important because RNA sequencing gives insight into which genes are active in a sample at a particular time. Combining this with data on proteins, lipids, and metabolites provides a much clearer picture of what’s happening in a cell.

Why This is Important
By making it easier to study RNA alongside proteins, lipids, and metabolites, mBAMM helps scientists better understand complex biological processes. This method improves sample characterization, meaning researchers can get more detailed and accurate data about how cells function or respond to different conditions, such as disease or treatment.
For example, in cancer research, understanding how RNA and proteins interact can lead to new insights into tumor growth and how to stop it. In personalized medicine, multi-omics could help doctors tailor treatments to a patient’s unique molecular profile.
The Future of Multi-Omics
The introduction of mBAMM represents a major step forward in multi-omics research. By enabling more comprehensive sample analysis, this method could accelerate discoveries in a wide range of fields, from disease research to drug development. And as more bioinformatic tools are developed to analyze this type of data, scientists will be able to uncover even more about the diversity and complexity of biological systems.
In short, mBAMM brings us one step closer to understanding the full puzzle of life at the molecular level, offering exciting possibilities for the future of biology and medicine.

Hot Topics

Related Articles